SV

Street Verdict

Analyst Scorecard

A record of what Rahul Ghose said publicly, with the source. Not advice.

Pending — not yet graded
“Bullish on pharma stocks like Biocon, Lupin, and Dr Reddy's, which are in a strong uptrend. Any dip in these stocks is seen as a potential buying opportunity, aligning with the broader healthcare sector's defensive appeal amid volatility.”

Rahul Ghose’s track record (trackable calls only): 4 graded calls · 95% CI 0–49%

Nifty PharmaBullishCalled 22 Jan 2025
Verdict:PENDING

This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.

Read the original articleSee Rahul Ghose’s full track record